Insiders Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-28 am EDT			5-day change	1st Jan Change
4,151 ^JPY	+0.48%		-0.34%	+2.39%

May. 16	Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment	MT
May. 15	Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Takeda Pharmaceutical Company Limited Announces Demise of its Board Member, Olivier Bohuon	May. 09	CI
Takeda Pharmaceutical Names Milano Furuta as Chief Financial Officer	Feb. 01	MT
Top Stories at Midday: Chicago PMI Shifts Back to Contraction; Alibaba Loses JD.com Antitrust Case; BuzzFeed President to Resign; Pfizer, Other Drugmakers Plan Price Increases; Boeing Says China 737 Max Jets Back in Service	Dec. 29	MT
Antisense Therapeutics Appoints CEO/Managing Director	23-08-06	MT
Takeda Pharmaceutical Company Limited Announces Board Changes	23-06-28	CI
Takeda Pharmaceutical Company Limited Announces Masato Iwasaki, Representative Director Expresses His Intention to Retire on June 28Th	23-03-30	CI
Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO	23-03-29	AN
Takeda Named Global Top Employer for Sixth Consecutive Year	23-01-16	BU
Takeda Pharmaceutical Company Limited Announces New Assignments of Directors	22-06-29	CI
Takeda Pharmaceutical Company Limited Announces Board Appointments	22-06-29	CI
OncoSec Medical Names Robert Arch CEO; Shares Rise Early	22-04-29	MT
Takeda Pharmaceutical Company Limited Announces Executive Changes	22-04-01	CI
Former Takeda vaccine chief to lead new COVID antiviral venture Aerium	22-03-22	RE
Takeda Announces Management Changes	22-02-03	CI
Takeda Named Global Top Employer for Fifth Consecutive Year	22-01-19	BU
Takeda Announces New Assignments of Directors	21-06-29	CI
Takeda Pharmaceutical Company Limited Announces Retirement of Yasuhiko Yamanaka as Director and Member of Audit and Supervisory Committee	21-05-28	CI
Takeda Announces Directorate Changes	21-03-31	CI
Takeda Pharmaceutical Company Limited Announces Executive Changes	21-03-15	CI
Nabriva Therapeutics : Names Daniel Dolan CFO	21-02-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Insiders

Filters